• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌中的表皮生长因子受体:与类固醇受体及其他预后因素的比较

Epidermal growth factor receptor in human breast cancer comparison with steroid receptors and other prognostic factors.

作者信息

Cerra M, Cecco L, Montella M, Tuccillo F, Bonelli P, Botti G

机构信息

Biochemistry Department, National Cancer Institute Fondazione G. Pascale, Napoli, Italy.

出版信息

Int J Biol Markers. 1995 Jul-Sep;10(3):136-42. doi: 10.1177/172460089501000302.

DOI:10.1177/172460089501000302
PMID:8551055
Abstract

The relationship between epidermal growth factor receptor (EGFR) status and various prognostic factors was investigated in 70 human breast cancer specimens. Epidermal growth factor receptor was determined by radioligand binding assay, standardized by the EORTC Receptor Study Group, using hydroxyapatite to separate receptor-bound and free ligand. The percentage of EGFR positivity was 80% when the cutoff was set at 5 fmol/mg of membrane protein; this percentage was among the highest hitherto reported. Regression analysis of EGFR versus ER and PR levels confirmed an inverse relationship between EGFR and ER (p = 0.022) as well as between EGFR and PR (p = 0.024). Univariate analysis of the EGFR data stratified according to steroid hormone receptor status showed EGFR to be negatively associated with ER and PR. No association was found between EGFR and menopausal status, axillary lymph node involvement, tumor size, and differentiation grade. A direct association between EGFR status and Ki-67 positive cell rate could be demonstrated.

摘要

在70例人类乳腺癌标本中研究了表皮生长因子受体(EGFR)状态与各种预后因素之间的关系。表皮生长因子受体通过放射性配体结合试验测定,该试验由欧洲癌症研究与治疗组织(EORTC)受体研究组标准化,使用羟基磷灰石分离受体结合的配体和游离配体。当将临界值设定为5 fmol/mg膜蛋白时,EGFR阳性率为80%;该百分比是迄今报道的最高百分比之一。EGFR与雌激素受体(ER)和孕激素受体(PR)水平的回归分析证实,EGFR与ER之间存在负相关(p = 0.022),EGFR与PR之间也存在负相关(p = 0.024)。根据类固醇激素受体状态对EGFR数据进行单因素分析,结果显示EGFR与ER和PR呈负相关。未发现EGFR与绝经状态、腋窝淋巴结受累、肿瘤大小及分化程度之间存在关联。EGFR状态与Ki-67阳性细胞率之间存在直接关联。

相似文献

1
Epidermal growth factor receptor in human breast cancer comparison with steroid receptors and other prognostic factors.人乳腺癌中的表皮生长因子受体:与类固醇受体及其他预后因素的比较
Int J Biol Markers. 1995 Jul-Sep;10(3):136-42. doi: 10.1177/172460089501000302.
2
Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.三阴性乳腺癌(TNBC)患者中生存素和 EGFR 蛋白表达的预后价值。
Target Oncol. 2014 Dec;9(4):349-57. doi: 10.1007/s11523-013-0300-y.
3
Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.原发性乳腺癌与同步腋窝淋巴结转移之间激素受体、人表皮生长因子受体-2和Ki-67的不一致性。
J BUON. 2018 Dec;23(7):60-66.
4
Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.基于生物标志物组进行乳腺癌预后预测的亚型分类:相关性与指征
Int J Nanomedicine. 2014 Feb 21;9:1039-48. doi: 10.2147/IJN.S58270. eCollection 2014.
5
Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.浸润性导管癌患者中Ki-67、雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2/neu(Her2/neu)、p21、表皮生长因子受体(EGFR)和拓扑异构酶II-α(TOP II-α)表达之间的关系及其与预后的相关性。
Asian Pac J Cancer Prev. 2015;16(2):823-9. doi: 10.7314/apjcp.2015.16.2.823.
6
Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.浸润性乳腺癌的预后变量:粉刺型与非粉刺型原位成分的作用。
Ann Surg Oncol. 1995 Sep;2(5):440-4. doi: 10.1007/BF02306378.
7
Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology.人类乳腺癌中的表皮生长因子受体:检测方法标准化的呼吁
Eur J Cancer. 1992;28(2-3):693-7. doi: 10.1016/s0959-8049(05)80128-5.
8
Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.脆性组氨酸三联体蛋白、含WW结构域的氧化还原酶蛋白Wwox和激活蛋白2γ的表达水平与乳腺癌的基础表型相关。
Cancer. 2009 Feb 15;115(4):899-908. doi: 10.1002/cncr.24103.
9
The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.原发性乳腺癌与同期腋窝淋巴结转移中激素受体和 HER2 状态的病例对照比较。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1559-1565. doi: 10.31557/APJCP.2020.21.6.1559.
10
Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.乳腺癌中的Ki67指数:与其他预后标志物的相关性及在巴基斯坦患者中的潜力
Asian Pac J Cancer Prev. 2013;14(7):4353-8. doi: 10.7314/apjcp.2013.14.7.4353.

引用本文的文献

1
Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer.肝素酶介导拉帕替尼耐药脑转移乳腺癌的新机制。
Neoplasia. 2015 Jan;17(1):101-13. doi: 10.1016/j.neo.2014.11.007.
2
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.三阴性炎性和非炎性乳腺癌分子亚型分布的比较。
Breast Cancer Res. 2013 Nov 25;15(6):R112. doi: 10.1186/bcr3579.
3
Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer.
沉默激酶相互作用的微管相关蛋白 stathmin 基因通过抑制表皮生长因子受体表达的乳腺癌中 Ser¹⁰ p27 的磷酸化增强厄洛替尼敏感性。
Mol Cancer Ther. 2010 Nov;9(11):3090-9. doi: 10.1158/1535-7163.MCT-10-0362. Epub 2010 Nov 2.
4
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer.表皮生长因子受体酪氨酸激酶抑制剂可逆转炎性乳腺癌的间充质上皮表型并抑制转移。
Clin Cancer Res. 2009 Nov 1;15(21):6639-48. doi: 10.1158/1078-0432.CCR-09-0951. Epub 2009 Oct 13.
5
Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells.在HER2过表达的乳腺癌细胞中,拉帕替尼的活性与EGFR表达水平无关。
Mol Cancer Ther. 2008 Jul;7(7):1846-50. doi: 10.1158/1535-7163.MCT-08-0168.